Trump Might Have Just Done Something That Could Revive the Allergan-Pfizer Merger

The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.

Author:: TheStreet Staff
Publish date:: Apr 24, 2017 7:51 AM EDT

The White House on Friday unveiled a new executive order instructing the Treasury Department to find and review tax regulations since the beginning of 2016 and make recommendations on modifying or repealing any they see as overly complex and burdensome. The order could potentially open the door for pharmaceutical giants Allergan (AGN) - Get Report and Pfizer (PFE) - Get Report to take another whack at the $160 billion deal squashed by Obama regulations in 2016.

"Maybe Pfizer would go back with Allergan," said New York-based analyst and former Lehman Brothers managing director Bob Willens. "I'm sure they still want to do the deal, and the only thing that's prevented it is those regulations."

This article was written by a staff member of TheStreet.